We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Arizona Cancer Center Biospecimen Repository

This study is currently recruiting participants.
Verified November 2015 by University of Arizona
Sponsor:
ClinicalTrials.gov Identifier:
NCT00896935
First Posted: May 12, 2009
Last Update Posted: December 2, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Arizona
  Purpose

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.


Condition Intervention
Cancer Other: biologic sample preservation procedure

Study Type: Observational
Official Title: Arizona Cancer Center Biospecimen Repository

Further study details as provided by University of Arizona:

Primary Outcome Measures:
  • Provision of tissue samples and biospecimens for translational study [ Time Frame: An eletronic record of the specimens is kept in a secure, web-based database. Follow-up information from patients will be obtained from the patient medical record, and updated every 6 months ]

Biospecimen Retention:   Samples With DNA
Tissue will be collected and preserved from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing.

Estimated Enrollment: 10000
Study Start Date: July 2006
Estimated Primary Completion Date: July 2020 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: biologic sample preservation procedure
    biologic sample preservation procedure
Detailed Description:

OBJECTIVES:

  • Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer.
  • Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine.
  • Provide quality-controlled storage and management of the specimen bank.
  • Collect relevant clinical and pathologic information with appropriate privacy protection.
  • Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The goal of this protocol is to provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer by collecting and preserving tissue from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing. No additional tissue will be taken at the time of surgery other than that required for patient care, but additional blood and urine samples will be obtained at that time. This protocol is not limited to certain types of cancer.
Criteria

DISEASE CHARACTERISTICS:

  • Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

PRIOR CONCURRENT THERAPY:

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00896935


Contacts
Contact: Arizona Cancer Center at University of Arizona Health Sciences 520-626-0950

Locations
United States, Arizona
Arizona Cancer Center at University of Arizona Health Sciences Center Recruiting
Tucson, Arizona, United States, 85724-5024
Contact: Setsuko K. Chambers, MD    866-278-1554      
Sponsors and Collaborators
University of Arizona
National Cancer Institute (NCI)
Investigators
Principal Investigator: Setsuko K. Chambers, MD University of Arizona
  More Information

Responsible Party: University of Arizona
ClinicalTrials.gov Identifier: NCT00896935     History of Changes
Other Study ID Numbers: CDR0000597579
P30CA023074 ( U.S. NIH Grant/Contract )
UARIZ-06-0609-04
UARIZ-BIO#A06035
UARIZ-SRC18042
First Submitted: May 9, 2009
First Posted: May 12, 2009
Last Update Posted: December 2, 2015
Last Verified: November 2015

Keywords provided by University of Arizona:
cancer